Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
PARECOXIB IMPAIRS EARLY TENDON REPAIR BUT IMPROVES LATER REMODELING
Background: Cyclooxygenase inhibitors may inhibit bone repair through their action on the bone morphogenic protein system – their effect on tendon repair is not known.
Research question/s: Do cyclooxygenase inhibitors negatively affect early tendon repair?
Methodology::Subjects: Eighty rats that underwent an Achilles tendon transection.
Experimental procedure: Rats were randomly allocated to the following study groups according to drug administration 6.4 mg/kg body weight parecoxib (PC) daily or placebo (PL) – saline), timing of administration, and timing of sacrifice (8–14 days post injury): (1) PL0-5 D8 (PL days 0–5 sacrifice day 8 = 9); (2) PA0-5 D8 (PC days 0–5 sacrifice day 8 = 10); (3) PL0-5 D8 (PL days 0–5 sacrifice day 14 = 10); (4) PA0-5 D8 (PC days 0–5 sacrifice day 14 = 10); (5) PL6-14 D14 (PL days 6–14 sacrifice day 14 = 10); (6) PA6-14 D14 (PC days 6-14 sacrifice day 14 = 10). Tissue was subjected to biomechanical testing and histological analysis on day of sacrifice.
Measures of outcome: Biomechanical data at failure: (force (N), stiffness (N/mm), energy (N.mm), area (mm2), stress (MPa)), histological callus tissue maturity.
Day 8: early PC treatment caused a 27% decrease in force at failure (p = 0.007), a 25% decrease in maximum stress (p = 0.01), and a 31% decrease in energy uptake (p = 0.05)
Day 14: early PC treatment caused a decrease in stiffness (p = 0.004), while late PC treatment caused …